» Articles » PMID: 7392187

Incidence of Estrogen Receptor in Benign Nevi and Human Malignant Melanoma

Overview
Journal JAMA
Specialty General Medicine
Date 1980 Aug 22
PMID 7392187
Citations 9
Authors
Affiliations
Soon will be listed here.
Abstract

This study was performed as an initial step to evaluate the possible effects of steroid hormones on benign nevi. Cytoplasmic receptors for estrogen were found in nine (41%) of 21 benign nevi from melanoma patients. Ten (37%) of 27 melanoma tumor tissues also had receptor for estrogen. Benign nevi from 17 normal persons had no estrogen receptor activity. The similar incidence of estrogen receptor in benign nevi from melanoma patients and in melanoma tissue itself, compared with the absence of receptor in benign nevi from a normal population, suggest that steroid hormones such as estrogen may represent a molecular alteration associated with a potential pathophysiologic transformation of a benign nevus to its malignant counterpart.

Citing Articles

Medical dermatologic conditions in transgender women.

Mundluru S, Larson A Int J Womens Dermatol. 2019; 4(4):212-215.

PMID: 30627619 PMC: 6322154. DOI: 10.1016/j.ijwd.2018.08.008.


Correlations Between Cutaneous Malignant Melanoma and Other Cancers: An Ecological Study in Forty European Countries.

Fernandez-Crehuet Serrano P, Serrano J, Allam M, Navajas R Int J Prev Med. 2016; 7:73.

PMID: 27217938 PMC: 4872481. DOI: 10.4103/2008-7802.181759.


Melanocytic nevi as biomarkers of breast cancer risk.

Fuhrman B, Cardenas V PLoS Med. 2014; 11(6):e1001661.

PMID: 24915464 PMC: 4051632. DOI: 10.1371/journal.pmed.1001661.


[Melanoma and pregnancy].

Erfurt-Berge C, Kaempgen E Hautarzt. 2010; 61(12):1040-5.

PMID: 21076805 DOI: 10.1007/s00105-010-2005-9.


Oral contraceptive use and risk of melanoma in premenopausal women.

Feskanich D, Hunter D, Willett W, Spiegelman D, Stampfer M, Speizer F Br J Cancer. 1999; 81(5):918-23.

PMID: 10555769 PMC: 2374297. DOI: 10.1038/sj.bjc.6690787.